“ Adherence and Or Discontinuation of Imatinib Mesylate in Patients With Chronic Myeloid Leukemia ”. 2016. Brazilian Journal of Pharmaceutical Sciences 52 (4): 581-89. https://doi.org/10.1590/s1984-82502016000400001.